Jacques Friborg
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 16
- HIV/AIDS Research and Interventions 3
- Epidemiology 13
- Hepatitis B Virus Studies 7
- Liver Disease Diagnosis and Treatment 5
- Cytomegalovirus and herpesvirus research 3
- Co-authors
- Wing‐Pui Kong (1 shared paper)Michael O. Hottiger (1 shared paper)Richard J. Colonno (5 shared papers)Éric A. Cohen (6 shared papers)Gary J. Nabel (4 shared papers)Wing-Pui Kong (3 shared papers)Fiona McPhee (13 shared papers)S Carrière (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Journal of Virology (5 papers)Virology (4 papers)American Journal of Physiology-Legacy Content (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Jacques Friborg
40 papers receiving 2.0k citations
Jacques Friborg's Hit Papers
Peers
Comparison fields: 5 of 100
- Virology 619
- Infectious Diseases 763
- Hepatology 326
- Oncology 773
- Epidemiology 882
Countries citing papers authored by Jacques Friborg
This map shows the geographic impact of Jacques Friborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Friborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Friborg more than expected).
Fields of papers citing papers by Jacques Friborg
This network shows the impact of papers produced by Jacques Friborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Friborg. The network helps show where Jacques Friborg may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacques Friborg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | p53 inhibition by the LANA protein of KSHV protects against cell death Hit paper breakdown → | 1999 | 573 |
| 2 | 1997 | 139 | |
| 3 | 2012 | 139 | |
| 4 | 2003 | 130 | |
| 5 | 2002 | 126 | |
| 6 | 2004 | 113 | |
| 7 | 2012 | 86 | |
| 8 | 1999 | 66 | |
| 9 | 2014 | 61 | |
| 10 | 1998 | 55 | |
| 11 | 1995 | 55 | |
| 12 | 1969 | 48 | |
| 13 | 1997 | 47 | |
| 14 | 2005 | 47 | |
| 15 | 1995 | 45 | |
| 16 | 1992 | 44 | |
| 17 | 2012 | 41 | |
| 18 | 1998 | 39 | |
| 19 | 2001 | 33 | |
| 20 | 1971 | 33 |
About Jacques Friborg
Jacques Friborg is a scholar working on Infectious Diseases, Epidemiology, Virology, Hepatology and Oncology, having authored 41 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (11 papers), Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (7 papers), Viral-associated cancers and disorders (5 papers), Liver Disease Diagnosis and Treatment (5 papers), HIV/AIDS Research and Interventions (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). The work is most often cited by research in Virology (619 citations), Infectious Diseases (763 citations), Hepatology (326 citations), Oncology (773 citations) and Epidemiology (882 citations). Jacques Friborg has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Wing‐Pui Kong, Michael O. Hottiger, Richard J. Colonno, Éric A. Cohen, Gary J. Nabel, Wing-Pui Kong, Fiona McPhee, S Carrière, Ronald E. Rose and Kimberly E. Foreman. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Virology, Virology, American Journal of Physiology-Legacy Content and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.